UPDATE 1-Poll shows 66 pct of California voters favor drug price initiative
(Adds background, details of U.S. legislation)
By By Deena Beasley
Sept 15 (Reuters) - An initiative on California's November ballot aimed at reining in prescription drug prices is favored by 66 percent of state voters, according to a new poll released on Thursday.
The California Drug Price Relief Act, also known as Proposition 61, seeks to restrict state-run health programs from paying more for medications than prices paid by the U.S. Department of Veterans Affairs, which is billed about 25 percent less for drugs than other government agencies.
The poll of more than 1,900 registered voters conducted by the University of Southern California (USC) and the Los Angeles Times found that 23 percent opposed the measure.
It was conducted in early September, amid a surge in public scrutiny of price hikes for Mylan NV's EpiPens, the emergency allergy injections.
Mylan is the latest company to be caught up in the growing outrage at big drug price hikes. Valeant Pharmaceuticals International Inc and Turing Pharmaceuticals have both been publicly criticized for price increases.
On Thursday, a bipartisan group of U.S. Senate and House members, including Arizona Senator John McCain, introduced legislation that would force drug makers to justify to the U.S. Department of Health and Human Resources price increases of more than 10 percent.
Opponents of the California measure, led by pharmaceutical companies like Pfizer Inc, Merck & Co Inc and Amgen Inc, have raised $87.5 million to try to stop the measure. Proponents, led by the AIDS Healthcare Foundation and the AARP, have raised around $10 million. Continued...